Discovery of novel ULK1 inhibitors through machine learning-guided virtual screening and biological evaluation
Future Medicinal Chemistry · 2024
DOI: 10.1080/17568919.2024.2385288 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Medicinal Chemistry, 2024. Verfasst von Miao-Miao Kong und 11 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China. Hauptthemen laut MEDLINE: Autophagy-Related Protein-1 Homolog, Machine Learning, Protein Kinase Inhibitors, Molecular Docking Simulation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Aim: Build a virtual screening model for ULK1 inhibitors based on artificial intelligence.Materials & methods: Build machine learning and deep learning classification models and combine molecular docking and biological evaluation to screen ULK1 inhibitors from 13 million compounds. And molecular dynamics was used to explore the binding mechanism of active compounds.Results & conclusion: Possibly due to less available training data, machine learning models significantly outperform deep learning models. Among them, the Naive Bayes model has the best performance. Through virtual screening, we obtained three inhibitors with IC50 of μM level and they all bind well to ULK1. This study provides an efficient virtual screening model and three promising compounds for the study of ULK1 inhibitors. [Box: see text].
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
- Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision & Brain Health), Wenzhou, Zhejiang, 325000, China.
- School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
- Faculty of Applied Sciences, Macao Polytechnic University, Macao, SAR, China.
- The Eye Hospital, School of Ophthalmology & Optometry, Wenzhou Medical University, Wenzhou, 325027, China.
ORCID-Profile: Miao-Miao Kong, Wu-Lan Li
Zitieren
APA
Kong, M. M., Wei, T., Liu, B., Xi, Z. X., Ding, J. T., Liu, X., Li, K., Qin, T. L., Qian, Z. Y., Wu, W. C., Wu, J. Z., & Li, W. L. (2024). Discovery of novel ULK1 inhibitors through machine learning-guided virtual screening and biological evaluation. Future Medicinal Chemistry. https://doi.org/10.1080/17568919.2024.2385288
Vancouver
Kong MM, Wei T, Liu B, Xi ZX, Ding JT, Liu X, et al. Discovery of novel ULK1 inhibitors through machine learning-guided virtual screening and biological evaluation. Future Medicinal Chemistry. 2024. doi:10.1080/17568919.2024.2385288
BibTeX
@article{Kong2024,
author = {Kong, Miao-Miao and Wei, Tao and Liu, Bo and Xi, Zi-Xuan and Ding, Jun-Tao and Liu, Xin and Li, Ke and Qin, Tian-Li and Qian, Zhen-Yong and Wu, Wen-Can and Wu, Jian-Zhang and Li, Wu-Lan},
title = {Discovery of novel ULK1 inhibitors through machine learning-guided virtual screening and biological evaluation},
journal = {Future Medicinal Chemistry},
year = {2024},
doi = {10.1080/17568919.2024.2385288}
}
EUVIMED